YOUR SEARCH FOR Text 211 RESULTS
141 of Total
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a
… (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma January 5, 2026 … ® ), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, and …
142 of Total
Terms of Use | Incyte.com
… link to this notice are provided by Incyte Corporation ("Incyte"). PLEASE READ AND REVIEW … by U.S. residents who are at least eighteen (18) years of age. You should not construe …
143 of Total
Incyte Leadership | Incyte.com
… and a member of the Company’s Board of Directors. With over three decades of industry … a global business with fifty products, $16 billion in revenue and approximately 8,000 …
144 of Total
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalido
… in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory … milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for …
145 of Total
Hematology and Oncology Research | Incyte.com
… Transforming the Treatment Landscape in Hematology and … contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463). Learn more …
146 of Total
Compliance & Transparency | Incyte.com
… business with the highest integrity, making information available as needed to our patients, … passed as part of healthcare reform in March 2010 and was in effect as of August 1, 2013. The …
147 of Total
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Derm
… (AAD) Annual Meeting March 20, 2026 at 10:00 AM EDT PDF Version -New, late-breaking 54-week data for povorcitinib in hidradenitis suppurativa …
148 of Total
Consumer Health Data Privacy Policy | Incyte.com
… Health Data laws shall have the meaning afforded to it therein. Our Collection of Consumer … on our Privacy Web Form Toll-free Telephone . 1-855-446-2983 Email . Privacy@incyte.com Mail . …
149 of Total
Incyte.com Cookie Policy
… Incyte Cookie Policy Last Updated: March 12, 2025 In operating our websites, we may gather and store certain information about you and your …
150 of Total
Inflammation and Autoimmunity Research: Immune-Mediated Dermatologic Conditions | Incyte.Com
… approach and heritage in immunology formed the foundation of our company. Today, we … contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463). Learn more …